Search results
Results From The WOW.Com Content Network
Aventis Pasteur, the vaccine division of the Sanofi-Aventis Group, changes its name to Sanofi Pasteur. 2008: Sanofi Pasteur acquires Acambis plc, a biotech company. 2009: Sanofi Pasteur acquires major stake in Hyderabad-based Shantha Biotechnics. 2020: Sanofi Pasteur and GlaxoSmithKline have said they are starting clinical trials of their ...
The Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. [3] [4] The Sanofi–GSK COVID‑19 vaccine was approved for medical use in the European Union in November 2022.
Sanofi was founded in 1973 [5] as a subsidiary of Elf Aquitaine (a French oil company subsequently acquired by Total ), when Elf Aquitaine took control of the Labaz group, a pharmaceutical company formed in 1947 by Sociéte Belge de l'Azote et des Produits Chimiques du Marly; [6] Labaz developed benziodarone in 1957.
The U.S. government is to pay Sanofi and GlaxoSmithKline 2.1 billion dollars to cover vaccines for 50 million people. That works out at around 42 dollars per person inoculated. The award is the ...
1. Sign in to your My Account page. 2. Click My Wallet. 3. Click Payment Methods. 4. Click Add Credit or Debit Card. 5. Enter the required info. 6. Click Submit.
Title. CEO, Sanofi. Term. September 2019-. Predecessor. Olivier Brandicourt. Children. 3. Paul Hudson (born 14 October 1967) [2] is a British businessman, and the chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales.
For premium support please call: 800-290-4726 more ways to reach us
The applicant for this medicinal product is Sanofi Pasteur. Supemtek was approved for medical use in the European Union in November 2020. Australia authorised its first and cell-based vaccine in March 2021, based on an "eternal cell line" of a dog kidney. Because of the way it is produced, it produces better-matched vaccine (to the flu strains).